Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Boston Omaha
BOC
$429M
| $652K | ﹤0.01% |
55,834
-6,972
| -11% | -$86.1K |
|
3027
Aura Biosciences
AURA
$729M
| $650K | ﹤0.01% |
97,139
-37,924
| -28% | -$218K |
|
3028
SkinHealth Systems
SKIN
$94.9M
| $646K | ﹤0.01% |
726,009
-36,047
| -5% | -$44.3K |
|
3029
Western New England Bancorp
WNEB
$287M
| $643K | ﹤0.01% |
49,707
-6,703
| -12% | -$87.8K |
|
3030
FVCBankcorp
FVCB
$324M
| $641K | ﹤0.01% |
42,214
-5,191
| -11% | -$78K |
|
|
PINE
3031
Alpine Income Property Trust
PINE
$339M
| $640K | ﹤0.01% |
35,579
-3,152
| -8% | -$58.5K |
|
3032
SelectQuote
SLQT
$114M
| $627K | ﹤0.01% |
996,097
-119,574
| -11% | -$126K |
|
|
AIRJ
3033
Montana Technologies Corp
AIRJ
$302M
| $627K | ﹤0.01% |
249,627
+44,443
| +22% | +$150K |
|
3034
Citizens
CIA
$245M
| $626K | ﹤0.01% |
124,416
-13,458
| -10% | -$71.5K |
|
3035
PCB Bancorp
PCB
$400M
| $625K | ﹤0.01% |
27,777
-3,961
| -12% | -$88.5K |
|
3036
Flotek Industries
FTK
$935M
| $621K | ﹤0.01% |
36,588
-4,291
| -10% | -$73.7K |
|
3037
LCNB Corp
LCNB
$285M
| $620K | ﹤0.01% |
39,751
+1,607
| +4% | +$26.9K |
|
3038
BK Technologies
BKTI
$292M
| $619K | ﹤0.01% |
8,298
-702
| -8% | -$57K |
|
3039
Karat Packaging
KRT
$789M
| $619K | ﹤0.01% |
22,154
-2,194
| -9% | -$55.3K |
|
|
FBLA
3040
FB Bancorp
FBLA
$251M
| $614K | ﹤0.01% |
44,713
-9,707
| -18% | -$128K |
|
3041
Spok Holdings
SPOK
$221M
| $611K | ﹤0.01% |
56,035
-4,954
| -8% | -$63K |
|
3042
Park-Ohio Holdings
PKOH
$554M
| $611K | ﹤0.01% |
25,397
-1,609
| -6% | -$39.4K |
|
3043
Utah Medical Products
UTMD
$214M
| $610K | ﹤0.01% |
9,838
-595
| -6% | -$37.5K |
|
3044
Neurogene
NGNE
$696M
| $606K | ﹤0.01% |
30,058
+99
| +0.3% | +$1.92K |
|
3045
Paysign
PAYS
$486M
| $606K | ﹤0.01% |
102,645
-10,737
| -9% | -$43.5K |
|
3046
CytomX Therapeutics
CTMX
$705M
| $605K | ﹤0.01% |
128,796
+60,109
| +88% | +$305K |
|
3047
Citi Trends
CTRN
$524M
| $601K | ﹤0.01% |
13,865
-1,417
| -9% | -$64.6K |
|
|
HDSN
3048
Hudson Technologies
HDSN
$267M
| $600K | ﹤0.01% |
101,977
-13,339
| -12% | -$91.5K |
|
3049
Montauk Renewables
MNTK
$266M
| $599K | ﹤0.01% |
520,611
-24,038
| -4% | -$36.2K |
|
3050
DiaMedica Therapeutics
DMAC
$363M
| $599K | ﹤0.01% |
88,421
-8,459
| -9% | -$67K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.